Kiniksa Pharmaceuticals Statistics
Total Valuation
KNSA has a market cap or net worth of $1.40 billion. The enterprise value is $1.20 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.20B |
Important Dates
The last earnings date was Tuesday, April 23, 2024, before market open.
| Earnings Date | Apr 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KNSA has 70.94 million shares outstanding. The number of shares has increased by 1.26% in one year.
| Shares Outstanding | 70.94M |
| Shares Change (YoY) | +1.26% |
| Shares Change (QoQ) | -9.25% |
| Owned by Insiders (%) | 4.22% |
| Owned by Institutions (%) | 99.23% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 165.46.
| PE Ratio | 165.46 |
| Forward PE | n/a |
| PS Ratio | 4.65 |
| Forward PS | 3.36 |
| PB Ratio | 3.25 |
| P/FCF Ratio | 65.74 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 139.10 |
| EV / Sales | 3.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 56.32 |
Financial Position
The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.21 |
| Quick Ratio | 3.57 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.57 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.10% and return on invested capital (ROIC) is -6.88%.
| Return on Equity (ROE) | 2.10% |
| Return on Assets (ROA) | 1.70% |
| Return on Capital (ROIC) | -6.88% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | $29,125 |
| Employee Count | 297 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | -30.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.98% in the last 52 weeks. The beta is 0.32, so KNSA's price volatility has been lower than the market average.
| Beta (1Y) | 0.32 |
| 52-Week Price Change | +46.98% |
| 50-Day Moving Average | 18.99 |
| 200-Day Moving Average | 17.93 |
| Relative Strength Index (RSI) | 59.27 |
| Average Volume (30 Days) | 387,050 |
Short Selling Information
The latest short interest is 3.91 million, so 5.52% of the outstanding shares have been sold short.
| Short Interest | 3.91M |
| Short Previous Month | 3.64M |
| Short % of Shares Out | 5.52% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.11 |
Income Statement
In the last 12 months, KNSA had revenue of $301.77 million and earned $8.65 million in profits. Earnings per share was $0.12.
| Revenue | 301.77M |
| Gross Profit | 264.82M |
| Operating Income | -30.54M |
| Pretax Income | -21.56M |
| Net Income | 8.65M |
| EBITDA | -16.36M |
| EBIT | -21.56M |
| Earnings Per Share (EPS) | $0.12 |
Balance Sheet
The company has $213.55 million in cash and $12.14 million in debt, giving a net cash position of $201.41 million or $2.84 per share.
| Cash & Cash Equivalents | 213.55M |
| Total Debt | 12.14M |
| Net Cash | 201.41M |
| Net Cash Per Share | $2.84 |
| Equity / Book Value | 431.90M |
| Book Value Per Share | 6.09 |
| Working Capital | 206.38M |
Cash Flow
In the last 12 months, operating cash flow was $21.56 million and capital expenditures -$190,000, giving a free cash flow of $21.37 million.
| Operating Cash Flow | 21.56M |
| Capital Expenditures | -190,000 |
| Free Cash Flow | 21.37M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 87.75%, with operating and profit margins of -10.12% and 2.87%.
| Gross Margin | 87.75% |
| Operating Margin | -10.12% |
| Pretax Margin | -7.15% |
| Profit Margin | 2.87% |
| EBITDA Margin | -5.42% |
| EBIT Margin | -7.15% |
| FCF Margin | 7.08% |
Dividends & Yields
KNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.26% |
| Shareholder Yield | -1.26% |
| Earnings Yield | 0.62% |
| FCF Yield | 1.52% |
Analyst Forecast
The average price target for KNSA is $30.20, which is 52.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.20 |
| Price Target Difference | 52.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 20.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KNSA has an Altman Z-Score of 9.19 and a Piotroski F-Score of 4.
| Altman Z-Score | 9.19 |
| Piotroski F-Score | 4 |